ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Comparison Trial of White Light, Autofluorescence and Narrow Band Imaging Bronchoscopy (NWA)

This study is currently recruiting participants.
Verified by Maimonides Medical Center, October 2007

Sponsored by: Maimonides Medical Center
Information provided by: Maimonides Medical Center
ClinicalTrials.gov Identifier: NCT00548730
  Purpose

The purpose of the study is to compare the three methods of bronchoscopic imaging to determine what combination is optimum to identify neoplastic mucosal abnormalities. The ability to decrease the rate of false-positive and false negative findings of bronchoscopy also will be studied for each spectroscopic technique separately and for their combination.


Condition Intervention
Lung Cancer
Procedure: Bronchoscopy

MedlinePlus related topics:   Cancer    Lung Cancer   

U.S. FDA Resources

Study Type:   Observational
Study Design:   Cohort, Prospective
Official Title:   A Clinical Comparison Trial of White Light Bronchoscopy, Autofluorescence Bronchoscopy and Narrow Band Imaged Bronchoscopy

Further study details as provided by Maimonides Medical Center:

Primary Outcome Measures:
  • Degree of correlation between three different bronchoscopic images [ Time Frame: One day ]

Secondary Outcome Measures:
  • Elimination of false positives and negative bronchoscopic examinations for neoplasia [ Time Frame: One day ]

Biospecimen Retention:   Samples Without DNA

Biospecimen Description:

Endobronchial biopsies of normal and abnormal mucosa for histopathology


Estimated Enrollment:   100
Study Start Date:   October 2007
Estimated Study Completion Date:   December 2008

Groups/Cohorts Assigned Interventions
Observation
Patients with known or suspected malignancies of the lung and with a medical indication for a bronchoscopy
Procedure: Bronchoscopy
The endoscopic examination of the bronchial tree will be performed using a commercially available flexible fluorescence bronchoscope and the flexible white light videobronchoscope. Biopsies are taken of a normal region and all abnormal regions.

Detailed Description:

Patients with known or suspected malignancies of the lung and with a medical indication for a bronchoscopy will be invited to participate in the study. All patients must be over 18 years old and must sign informed consent. The endoscopic examination of the bronchial tree will be performed using a commercially available flexible fluorescence bronchoscope (11004BI; Karl Storz; Culver City, CA) and the flexible white light videobronchoscope (BF-T180; Olympus; Center Valley, PA). Both systems are available and in routine use at Maimonides Medical Center.

Images obtained will be photographed using both video recordings and parallel images of white light and imaged bronchoscopy. These digital images will be electronically stored and evaluated at a later time. Biopsies will be obtained of all suspected abnormalities. These will be correlated with the images.

Images will be identified as normal, suspect or abnormal based upon each modality independently, paired with the spectral image and all three combined. The control will be an area considered normal by all modes of bronchoscopy. Images will be graded at the time of bronchoscopy. Later, all images will be graded in a blind fashion by two independent bronchoscopists. Standard statistical analysis using paired Student's t test will be applied. We anticipate that the combination of one or more imaged bronchoscopy techniques will increase accuracy by 25%. Power calculation to detect such a difference will require 140 abnormal specimens. If 50% of patients examined have an abnormality, the study population will need to be around 300 patients.

Histopathology reports will be obtained on all specimens. Abnormal results will be discussed with the individual patient and appropriate procedures will be performed based upon best medical practices. These procedures and patient follow-up are beyond the scope of the study.

  Eligibility
Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample

Study Population

Any patient with known or suspected malignancies of the lung and with a medical indication for a bronchoscopy


Criteria

Inclusion Criteria:

  • Patients with lung abnormalities that have an indication for bronchoscopy

Exclusion Criteria:

  • Inability to tolerate bronchoscopy
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00548730

Contacts
Contact: Joseph LoCicero, MD     718-283-7272     jlocicero@maimonidesmed.org    
Contact: Richard S Lazzaro, MD     718-283-7272     rlazzaro@maimonidesmed.org    

Locations
United States, New York
Maimonides Medical Center     Recruiting
      Brooklyn, New York, United States, 11219
      Contact: Joseph LoCicero, MD     718-283-7272     jlocicero@maimonidesmed.org    
      Contact: Richard S Lazzaro, MD     718-283-7272     rlazzaro@maimonidesmed.org    
      Principal Investigator: Joseph LoCicero, MD            
      Sub-Investigator: Richard S Lazzaro, MD            

Sponsors and Collaborators
Maimonides Medical Center

Investigators
Principal Investigator:     Joseph LoCicero, MD     Maimonides Medical Center    
  More Information

Publications:
DaCosta RS, Wilson BC, Marcon NE. Light-induced fluorescence endoscopy of the gastrointestinal tract. Gastrointest Endosc Clin N Am. 2000 Jan;10(1):37-69, vi. Review.
 
Gono K, Obi T, Yamaguchi M, Ohyama N, Machida H, Sano Y, Yoshida S, Hamamoto Y, Endo T. Appearance of enhanced tissue features in narrow-band endoscopic imaging. J Biomed Opt. 2004 May-Jun;9(3):568-77.
 
Vincent BD, Fraig M, Silvestri GA. A pilot study of narrow-band imaging compared to white light bronchoscopy for evaluation of normal airways and premalignant and malignant airways disease. Chest. 2007 Jun;131(6):1794-9. Epub 2007 May 15.
 
Lee P, Brokx HA, Postmus PE, Sutedja TG. Dual digital video-autofluorescence imaging for detection of pre-neoplastic lesions. Lung Cancer. 2007 Oct;58(1):44-9. Epub 2007 May 29.
 
Ueno K, Kusunoki Y, Imamura F, Yoshimura M, Yamamoto S, Uchida J, Tsukamoto Y. Clinical experience with autofluorescence imaging system in patients with lung cancers and precancerous lesions. Respiration. 2007;74(3):304-8. Epub 2006 May 5.
 
Jang TW, Oak CH, Chun BK, Jung MH. Detection of pre-invasive endobronchial tumors with D-light/autofluorescence system. J Korean Med Sci. 2006 Apr;21(2):242-6.
 
Haussinger K, Becker H, Stanzel F, Kreuzer A, Schmidt B, Strausz J, Cavaliere S, Herth F, Kohlhaufl M, Muller KM, Huber RM, Pichlmeier U, Bolliger ChT. Autofluorescence bronchoscopy with white light bronchoscopy compared with white light bronchoscopy alone for the detection of precancerous lesions: a European randomised controlled multicentre trial. Thorax. 2005 Jun;60(6):496-503.
 

Study ID Numbers:   MMC07/06VA14
First Received:   October 22, 2007
Last Updated:   October 22, 2007
ClinicalTrials.gov Identifier:   NCT00548730
Health Authority:   United States: Institutional Review Board

Keywords provided by Maimonides Medical Center:
Bronchoscopy  
Endoscopy  
Image Enhancement  
Autofluorescence  
Narrow Band Image  

Study placed in the following topic categories:
Thoracic Neoplasms
Respiratory Tract Diseases
Lung Neoplasms
Lung Diseases

Additional relevant MeSH terms:
Respiratory Tract Neoplasms
Neoplasms
Neoplasms by Site

ClinicalTrials.gov processed this record on September 05, 2008




Links to all studies - primarily for crawlers